Barbot et al developed a score for predicting survival for a patient with an advanced solid tumor. The authors are from Poitiers University Hospital in France.
Patient selection: inoperable and/or metastasized solid tumor
Parameters:
(1) Karnofsky score
(2) metastases
(3) serum albumin in g/L
(4) serum LDH in IU/L
Parameter
Finding
Points
Karnofsky score
>= 70
0
40 to 60
2
<= 30
4
metastases
0 or 1
2 or more
serum albumin
>= 33 g/L
-3
< 33 g/L
serum LDH
< 600 IU/L
>= 600 IU/L
1
total score =
= SUM(points for all 4 parameters) + 3
Interpretation:
• minimum score: 0
• maximum score: 10
• The higher the score the shorter the survival.
Total Score
Risk Group
Survival at 2 months
Survival at 4 Months
0 to 3
A
90%
82%
4 to 7
B
42%
24%
8 to 10
C
7.6%
0%
To read more or access our algorithms and calculators, please log in or register.
Purpose: To predict survival for a patient with an advances solid tumor using the prognostic score of Barbot et al.
Specialty: Hematology Oncology, Surgery, general
Objective: severity, prognosis, stage
ICD-10: Z51.5, C79.9, C00-C97,
